BDNF and depressive symptom measurement: OA treatment in depression-like mice (long-term corticosterone treatment) decreased serine/threonine protein kinase 1 (SGK1) levels and induced the brain-derived neurotrophic factor BDNF-AKT/mTOR pathway, increased sucrose preference, and decreased immobility time in the animals [102].